» Authors » Junyi Duan

Junyi Duan

Explore the profile of Junyi Duan including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 39
Citations 254
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Fang Y, Wang F, Jiang T, Duan J, Huang T, Liu H, et al.
Biosaf Health . 2025 Mar; 6(3):186-190. PMID: 40078726
Mpox is a zoonotic infectious disease caused by the mpox virus (MPXV). Historically, the majority of mpox cases have been documented in Central Africa. However, since May 2022, there has...
2.
Wang X, Yang X, Zhang X, Yan H, Jin J, Ma Z, et al.
Front Immunol . 2025 Mar; 16:1554409. PMID: 40070834
Objective: Both B-cell- and T-cell-mediated immunity are crucial for the effective clearance of viral infection, but little is known about the dynamic characteristics of SARS-CoV-2-specific B-cell and T-cell responses in...
3.
He Y, Zhang Y, Jiang T, Cai M, Sun G, Ma Y, et al.
BMC Infect Dis . 2025 Jan; 25(1):41. PMID: 39780061
An increasing number of treatment guidelines recommend rapid initiation of antiretroviral therapy (ART) after the diagnosis of human immunodeficiency virus (HIV) infection. However, data on the association between rapid ART...
4.
Yi J, Guo H, Jiang C, Duan J, Xue J, Zhao Y, et al.
Front Endocrinol (Lausanne) . 2024 Dec; 15:1462591. PMID: 39735642
Background: It is necessary to find latent indicators to predict the survival of alcohol-associated liver disease (ALD) patients. Leukocyte telomere length (LTL) was regarded as an indicator of prognosis in...
5.
Xie X, Han S, Wu Y, Huang T, Duan J, Li D, et al.
BMC Public Health . 2024 Oct; 24(1):2938. PMID: 39443906
Background: Peer support is a promising and significant way for people living with HIV (PLWH) to improve their health outcomes. Matching PLWH with HIV peer volunteers can effectively stimulate and...
6.
Fu L, Huang L, Gao Y, Zhu W, Cui Y, Wang S, et al.
BMJ Open . 2024 Sep; 14(9):e081293. PMID: 39277205
Introduction: Acupuncture is widely used for metabolic-associated fatty liver disease (MAFLD) treatment; however, the clinical efficacy has not been confirmed due to the lack of high-level evidence-based clinical practice. The...
7.
Ye J, Dong Y, Lan Y, Chen J, Zhou Y, Liu J, et al.
J Infect Dis . 2024 Aug; 230(6):1410-1421. PMID: 39189826
Background: National treatment guidelines of China evolving necessitates population-level surveillance of transmitted drug resistance (TDR) to inform or update HIV treatment strategies. Methods: We analyzed the demographic, clinical, and virologic...
8.
Ye J, Lan Y, Wang J, Feng Y, Lin Y, Zhou Y, et al.
J Infect Dis . 2024 Aug; 230(5):1202-1214. PMID: 39186695
Background: In 2016, China has implemented the World Health Organization's "treat all" policy. We aimed to assess the impact of significant improvements in the 95-95-95 targets on population-level human immunodeficiency...
9.
Liu H, Wang W, Zhang Y, Wang F, Duan J, Huang T, et al.
Emerg Microbes Infect . 2024 Jul; 13(1):2387442. PMID: 39082272
A large outbreak of monkeypox occurred in 2022, and most people lack immunity to orthopoxvirus. Smallpox vaccination is essential for preventing further smallpox outbreaks. This study evaluated the effectiveness, protection,...
10.
Wang X, Li Y, Jin J, Chai X, Ma Z, Duan J, et al.
Chin Med J (Engl) . 2024 Jul; 137(22):2734-2744. PMID: 39028115
Background: T-cell-mediated immunity is crucial for the effective clearance of viral infection, but the T-cell-mediated immune responses that are induced by booster doses of inactivated severe acute respiratory syndrome coronavirus...